Luncheon

Oct. 13 (Fri.) ,2017 12:00-13:00

Annex Hall
F203

【L-7】 Metabolon

Precision Metabolomics™ Illuminates New Paths for Medicine and Pharmaceutical R&D

The post-genome ear has led to new targets and precision medicine solutions but has also revealed staggering complexity. In response to this complexity, there is an escalation in the scale of next-generation sequencing initiatives, but also, a realization that complementary or alternative technologies are required. Technologies that provides a comprehensive, physiologically meaningful assessment and link to how a drug or disease affects a patient are key. This is what metabolomics does. Through its unique approach, Metabolon's Precision Metabolomics™ technology is proving to be a key ally for precision medicine and pharmaceutical R&D.

Precision Metabolomics™ Illuminates New Paths for Medicine and Pharmaceutical R&D

Kirk Beebe

Metabolon, Sr. Director, Applied Metabolomics

Close Window